Reports for SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
Company Name
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
12 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 2 (17%) | |
| Resolved: | 10 (83%) | |
Discontinuation Reports |
1 |
|
| To be discontinued: | 1 (100%) | |
| Discontinued: | 0 (0%) | |
| Reversed: | 0 (0%) | |
Late reports |
1 (8%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CAPRELSA | 100MG | TABLET | Avoided shortage | 2022-02-15 | 2022-06-30 | 155030 |
| CAPRELSA | 300MG | TABLET | Avoided shortage | 2022-02-15 | 2022-04-08 | 155058 |
| THYROGEN | 0.9MG | POWDER FOR SOLUTION | Resolved | 2022-01-13 | 2022-02-08 | 152688 |
| THYROGEN | 0.9MG | POWDER FOR SOLUTION | Resolved | 2022-05-16 | 2022-06-09 | 160682 |
| THYROGEN | 0.9MG | POWDER FOR SOLUTION | Resolved | 2022-10-28 | 2023-01-28 | 172865 |
| THYROGEN | 0.9MG | POWDER FOR SOLUTION | Resolved | 2023-03-15 | 2023-04-24 | 187119 |
| THYROGEN | 0.9MG | POWDER FOR SOLUTION | Resolved | 2023-05-05 | 2024-05-01 | 191764 |
| MYOZYME | 50MG | POWDER FOR SOLUTION | Resolved | 2022-11-30 | 2022-12-07 | 176406 |
| MABCAMPATH | 30MG | SOLUTION | Resolved | 2020-02-21 | 2020-06-18 | 106962 |
| MABCAMPATH | 30MG | SOLUTION | Resolved | 2023-10-18 | 2023-12-19 | 207255 |
| CAPRELSA | 100MG | TABLET | Resolved | 2023-01-30 | 2023-02-08 | 182714 |
| AUBAGIO | 14MG | TABLET | Resolved | 2022-04-25 | 2022-05-04 | 159348 |
Showing 1 to 12 of 12
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AUBAGIO | 14MG | TABLET | To be discontinued | 2024-05-02 | 2024-05-02 | 226847 |
Showing 1 to 1 of 1